Buy Ocrevus Ocrelizumab 300mg Injection Online – GlobMedIndia United States of America - California, Washington, Chicago, Los Angeles, Houston, Phoenix, Austin, Columbus, Philadelphia, San Antonio, San Diego, Dallas, and Jacksonville. - GLOB MED INDIA PHARMA EXPORTER,Washington, USA

Ocrevus Ocrelizumab 300mg Injection

Ocrevus (Ocrelizumab 300 mg Injection) is a targeted biologic therapy used primarily for the treatment of multiple sclerosis (MS). It is a monoclonal antibody designed to selectively target CD20-positive B cells, which play a key role in the immune system’s attack on nerve cells in MS. By reducing these harmful B cells, Ocrevus helps slow disease progression, reduce relapses, and preserve neurological function.

📞 Contact Details – Place Your Order

💬 WhatsApp: +91 9730316395
📞 Phone: +91 9730316395
📧 Email: info@globmedindia.com

Composition and Content

Active Ingredient: Ocrelizumab
Strength: 300 mg per vial
Form: Sterile solution for intravenous infusion
Class: Humanized monoclonal antibody (anti-CD20)

How to Use

Ocrevus is administered intravenously (IV infusion) under medical supervision in a hospital or clinical setting.

Administration Guidelines:

Given as a slow IV infusion
Patients are monitored during and after infusion for reactions
Pre-medications (antihistamines, steroids) are usually given to reduce side effects

Dosage

Typical dosing schedule:

Initial Dose:
- 300 mg infusion followed by another 300 mg after 2 weeks
Maintenance Dose:
- 600 mg every 6 months

Note: Dosage may vary based on patient condition and physician recommendation.

Uses & Indications

Ocrevus is approved for:

Relapsing forms of Multiple Sclerosis (RMS)
Primary Progressive Multiple Sclerosis (PPMS)

Treatment Benefits

Slows disability progression
Reduces frequency of relapses
Decreases brain lesion activity (MRI evidence)
Improves long-term disease control

Advantages

First therapy approved for both RMS and PPMS
Long dosing interval (once every 6 months)
Targeted immune suppression (more precise than traditional therapies)
Proven clinical efficacy in slowing disease progression

Storage Conditions

Store at 2°C to 8°C (refrigerated)
Do not freeze or shake
Keep in original packaging to protect from light
Use under professional medical supervision only

Alternative Indian Brands for Ocrelizumab

While Ocrevus is the original brand, biosimilars and alternatives may be available or emerging in India. Common alternatives in similar therapeutic categories (depending on availability and doctor guidance) include:

Rituximab-based therapies (off-label in MS):
- Reditux (Dr. Reddy’s)
- Ristova (Intas Pharmaceuticals)

Note: Direct biosimilar versions of Ocrelizumab may have limited availability in India. Always consult a specialist before switching.